Research

Research

At California Retina Consultants and Research Foundation, we are currently conducting over 30 different retrospective and prospective studies testing treatments to improve vision for those suffering from diabetic macula edema, dry AMD, wet AMD, and other blinding retinal diseases.

 

One mission of our practice is to provide patients the opportunity to participate locally in national clinical trials of new treatments for severe retinal diseases. The doctors of California Retina Consultants, have been recognized for their involvement in numerous national and international clinical trials of novel treatments for complications of diabetic retinopathy, macular degeneration, retinal detachments, and ocular injuries.

 

Participation in a clinical trial is completely voluntary. Eligibility for enrollment into a particular trial is determined through a screening process that varies from study to study. Because of the specific nature of your disease, you may not be eligible for participation. If you decide not to participate or are deemed ineligible, the doctors will continue to care for your eyes and provide you with the highest standard of care available.

 

If you’re interested in learning more about participating in one of our current or upcoming clinical trials, or just have general questions about research related to your particular condition, please give us a call at 805.963.1648.

Clinical Investigators

Avery

Robert Avery, MD

Dante Pieramici, MD
Castellarin
Alessandro Castellarin, MD
Couvillion, MD
Stephen Couvillion, MD
Nathan Steinle, MD
Dr. Dhoot
Dilsher Dhoot, MD
Dr. Learned
Daniel Learned, MD
Dr. Yang
Dong Yang, MD
Dr. Clark
Andrew Clark, MD, PhD
Dr. Gupta
Ankur Gupta, MD, MS

Clinical Research Team

Soila Carlos

Solia Carlos

Director of Research Operations

Anthony Lopez

Anthony Lopez

Research Operations Administrator

Nancy Castillo

Nancy Castillo

Research Manager

Jerry Smith

Research Photographer Supervisor

Rina Odina

Research Supervisor

Natasha Edwards

Natasha Edwards

Lead Research Recruitment Coordinator

Trial Indications

  • Gene Therapy
  • Uveitis
  • Geographic Atrophy (GA)
  • Neovascular Age Related Macular Degeneration
  • Diabetic Retinopathy (DR)
  • Non-Proliferative
  • Diabetic Retinopathy (NPDR)
  • Diabetic Macular Edema (DME)
  • Polypoidal Choroidal Vasculopathy (PCV)
    – Port Delivery Systems trails (PDS)
    – Tyrosine Kinase Inhibitor (TKI)